
Vivani Medical (VANI) Stock
Small medical device company developing urology technologies. Here's the price, business snapshot, and what's worth knowing about Vivani Medical in August 2026.
Vivani Medical Inc (ticker VANI) is a small‑cap medical device company with a market capitalisation of around US$99.5m. Investors should know it operates in the healthcare sector developing and/or commercialising medical technologies; value is often driven by clinical progress, regulatory clearances and commercial partnerships. As a smaller company it typically has limited revenue visibility, greater share‑price volatility and dependence on successful trial outcomes and reimbursement decisions. Key factors to monitor include cash runway, management execution, any partnership or distribution agreements, and milestone announcements that could materially affect outlook. Be mindful of funding and dilution risk if additional capital is required. This is a general, educational overview — not personalised financial advice. Returns are not guaranteed and the stock may suit investors with a higher risk tolerance and a long‑term horizon.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Vivani Medical's stock with a target price of $7.5, indicating strong growth potential.
Financial Health
Vivani Medical Inc shows steady financial performance with reasonable cash flow and book value.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Clinical & Regulatory Catalysts
Progress in trials or approvals can be major price drivers, offering upside but also sharp downside if results disappoint.
Commercial Partnerships Matter
Distribution or manufacturing agreements can validate technology and support revenue growth, though contract execution may take time.
Small‑cap Market Dynamics
Smaller market capitalisation means higher volatility and liquidity risk; this stock may suit investors comfortable with swings and potential dilution.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.